Davenport, IA – According to the statement, Moderna has begun a rolling submission to the Food and Drug Administration of data from its studies of the two-dose vaccine.
We already know that the Moderna’s vaccine already has been cleared for emergency use by the FDA and regulators in numerous other countries.
More than 124 million doses have been administered in the United States.
The FDA will check the information to see if the vaccine meets stringent criteria for full licensure.
Moderna is the second COVID-19 vaccine maker to seek full approval, following Pfizer and German partner BioNTech.
